Cell Therapeutics Inc (NASDAQ:CTIC)

CAPS Rating: 1 out of 5

The Company develops, acquires and commercializes novel treatments for cancer and focuses its research and in-licensing activities on identifying and developing new, less toxic and effective ways to treat cancer.

Recs

0
Player Avatar OBAMABB (< 20) Submitted: 6/26/2012 7:10:59 PM : Outperform Start Price: $2.95 CTIC Score: -86.75

Keep Bashing CTIC 65 times in 6 months means you are trying to manipulate the stock your buddies must be real short!

Featured Broker Partners


Advertisement